Several public sector organizations have committed $500 million to six funds managed by Bamboo Capital Partners under a new investment platform dedicated to achieving the UN sustainable development goals (SDGs).
Having closed its ninth fund at $14 billion, Lexington Partners is hunting for assets in a secondary market that is becoming ever larger and diverse. Asia is on the agenda, whether it’s GP-led restructurings or LP portfolios
Ares Management has agreed to buy a controlling stake in SSG Capital, an Asia-focused credit and special situations fund manager with approximately $6.2 billion in assets under management, including $3.9 billion in dry powder.
US-based Massachusetts Mutual Life Insurance Company (MassMutual) has established a second venture capital fund for Southeast Asia with a corpus of $100 million.
Baring Private Equity Asia has closed its seventh fund with commitments of $6.5 billion. It is the fourth-largest pan-Asian private equity vehicle ever raised.
Wipro Ventures, a venture capital investment arm of the eponymous Indian enterprise software provider, has raised $150 million for its second fund.
Sammasan Capital, a credit investment firm established by two former executives with GE Capital in Asia, is looking to raise up to $300 million for its debut fund.
New Delhi-headquartered venture capital firm Venture Highway has raised $78.6 million for its second fund, which will focus on early-stage investments in technology start-ups.
VIG Partners believes its recent $810 million fundraise validates the firm's middle-market strategy and spur the emergence of new domestic GPs in this area
China’s private consumption story continues to be a driving force for PAG Asia Capital. The GP also won prizes for Deal of the Year - Large Cap and Fundraising of the Year - Large Cap
Australia’s AMP Capital has closed its latest global infrastructure fund with $3.4 billion in commitments. The target was $3 billion.
Ankur Capital, an Indian early-stage investor focused on healthcare and agriculture technology investments, has reached a first close of INR2.4 billion ($33 million) on its second fund.
KKR has committed an additional $150 million in funding to its India-based non-banking financial company (NBFC), citing strong growth prospects for credit investment in the country.
China-focused venture capital fund-of-funds Unicorn Capital Partners, which has raised $350 million for its latest vehicle, expects consolidation in the tech investment space as underperforming GPs flounder
Ascendent Capital Partners has closed its third China fund with more than $1 billion in commitments, having increased the hard cap.
Longzhong Xinyi, a venture capital firm established by Hailong Xiang (pictured), formerly a senior executive at Baidu, has raised RMB200 million ($29 million) for its debut fund.
Chinese smart sensor maker Hesai Technology has raised a $173 million Series C round led by Germany’s Bosch Group and existing investor Lightspeed China Partners.
VIG Partners has closed its fourth Korea-focused fund at $810 million, with approximately half the commitments coming from international investors. This compares to 30% for Fund III, which closed at $600 million in 2017.
A selection of the key fundraising, investment and exit events - presented in chronological order - from the past 12 months
Canada Pension Plan Investment Board (CPPIB) has committed $225 million to India Resurgence Fund (India RF), a distressed assets investment platform established by Bain Capital Credit and Piramal Enterprises.
Indonesia-based early-stage investor Alpha JWC Ventures has closed its second fund oversubscribed at $123 million.
China-headquartered Asian Infrastructure Investment Bank (AIIB) is set to anchor two private equity funds, including an energy-focused vehicle, with a total commitment of $125 million.
Australia’s Blackbird Ventures has completed a GP-led secondary transaction whereby StepStone Global and HESTA have acquired interests from its debut fund for approximately A$100 million ($69 million).
Shanghai Kechow Pharma, a Chinese small molecule targeted drug developer, has raised a $45 million Series C round led by Decheng Capital.